About Salerno Pharmaceuticals
Salerno Pharmaceuticals is a Healthcare company based in Brooksville (United States) founded in 2006, and was acquired by The Courtney Group in June 2016. Pharmaceuticals for cholesterol treatment are developed by Salerno Pharmaceuticals. Salerno Pharmaceuticals offers products and services including FloLipid. Its focus areas include Life Sciences, Obesity and Drugs. Its competitors include Altimmune, Carmot and BioAge Labs; 3 of its 3 listed competitors have raised funding.
Company details
Salerno Pharmaceuticals was founded in 2006 and is headquartered in Brooksville, United States. Focus is placed on the development of cholesterol-treatment pharmaceuticals within the healthcare sector. Operations center on creating medications that address elevated cholesterol levels. The lead product, FloLipida liquid simvastatin formulationis employed as the initial liquid statin option. Risks of stroke, heart attack, and related cardiovascular issues are reduced through cholesterol level management facilitated by this product.
- Headquarters Brooksville, United States
- Stage Acquired
- SectorsHealthcare
- Website salernopharma.com
- Social LinkedIn X Facebook Instagram
- Acquired by The Courtney Group (Jun 2016)
- Legal Name Salerno Pharmaceuticals
- Investors
- Acquired byThe Courtney Group
(Jun 2016)
Products & Services of Salerno Pharmaceuticals
Salerno Pharmaceuticals offers a comprehensive portfolio of products and services, including FloLipid.
Liquid simvastatin to treat high cholesterol and lower heart disease risks.
Investors in Salerno Pharmaceuticals
Salerno Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Courtney Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking and private equity services are provided by The Courtney Group. | thecourtneygroup.com | Newport Beach, United States |
Investor details for Salerno Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Salerno Pharmaceuticals
2 dated milestones of Salerno Pharmaceuticals across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Salerno Pharmaceuticals is founded.
- Exit Acquired by The Courtney Group.
Competitors of Salerno Pharmaceuticals
Salerno Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Altimmune, Carmot and BioAge Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| altimmune.com | 1997 | Gaithersburg, United States | $58M | 17 | Vaccines for infectious diseases and solid tumors are developed. | |
| carmot.us | 2008 | Berkeley, United States | $385.52M | Disease-modifying therapies for metabolic diseases are developed. | ||
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. |
Detailed competitors of Salerno Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Salerno Pharmaceuticals
The website of Salerno Pharmaceuticals (salernopharma.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 63.4% vs previous month
Top companies in Obesity
3 companies that operate in the same segment as Salerno Pharmaceuticals (Obesity) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Salerno Pharmaceuticals
Salerno Pharmaceuticals was founded in 2006.
Salerno Pharmaceuticals is headquartered in Brooksville, United States. It is registered at Brooksville, Florida, United States.
Salerno Pharmaceuticals was founded in 2006 and is headquartered in Brooksville, United States. Focus is placed on the development of cholesterol-treatment pharmaceuticals within the healthcare sector. Operations center on creating medications that address elevated cholesterol levels. The lead product, FloLipida liquid simvastatin formulationis employed as the initial liquid statin option. Risks of stroke, heart attack, and related cardiovascular issues are reduced through cholesterol level management facilitated by this product.
Salerno Pharmaceuticals's top competitors include BioAge Labs, Carmot and Altimmune.
Salerno Pharmaceuticals offers FloLipid.
Salerno Pharmaceuticals has 1 investor. Key investors include The Courtney Group.
Salerno Pharmaceuticals operates through Salerno Pharmaceuticals.
Yes. Salerno Pharmaceuticals was acquired by The Courtney Group in June 2016.
